Generation Bio Co. (GBIO) - Long-Term Indebtedness

Official company branding of Generation Bio (GBIO)

Generation Bio Co. (GBIO) generates revenue by creating safe gene correction methods to combat orphan pathologies, receiving payments from pharmaceutical partners for joint research. Current genome editing laboratory capacities are engaged in research, while equipment is being calibrated for the production of trial batches. The integration of AI into bioreactors for drug synthesis optimizes formula screening, with the indicator standing at 0.02. The visualization of financial quotes on GURU.Markets is available below.

GBIO (generationbio.com) Company Long-Term Debt history from 07/04/2022 to 02/21/2026

Analytical breakdowns for Generation Bio Co.

- price and consensus price forecast:
Stock Price Generation Bio Co|GBIO - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Generation Bio|GBIO - Enterprise Value
- book capitalization data:
Net Asset Value per Share Generation Bio|GBIO - Company Book Value|Capitalization to Book Value Ratio generationbio.com|GBIO - Company Total Assets
- debt and liquidity data:
Debt to Capital Generation Bio Co.|GBIO - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Generation Bio Co|GBIO - Company Aggregate Debts|Debts to Book Capitalization Generation Bio|GBIO - Company Long-Term Liabilities|Amount of Current Liabilities Generation Bio
Summary company analytics:GBIO - Generation Bio Co.
Manufactured products of Generation Bio Corp

For Generation Bio Co. (GBIO), which is developing non-viral gene therapy, long-term liabilities record the aggregate of loans with maturities exceeding one year, reflecting the scale of external financing for R&D cycles. By analyzing the company's long-term debt volume, an investor can assess the stability of the capital structure: a stagnant indicator level without growth in royalty revenue signals operational stagnation and a dependence on borrowed funds.

Competitors of Generation Bio Co.

Company Long-Term Debts Tempus Labs TEM|Company Long-Term Debts QGEN|IONS - Long-Term Indebtedness|Company Long-Term Debts RGEN|RNA (Avidity Corp) - Long-Term Debt|Company Long-Term Debt CRISPR Therapeutics AG (CRSP)|Company Long-Term Indebtedness genedx.com|Ultragenyx - Company Long-Term Debts|Long-Term Debt BEAM (Beam Therapeutics Inc)|Company Long-Term Debt Sarepta Therapeutics Inc|Company Long-Term Loans and Borrowings Twist Bioscience Corp TWST|10x Genomics, Inc. - Company Long-Term Debts|intelliatx.com (NTLA) - Company Long-Term Debts|STOK - Company Long-Term Liabilities|BioLife Solutions Inc (BLFS) - Amount of Long-Term Liabilities|WVE: Company Long-Term Debts|Long-Term Debt Volume MAZE|Sionna Therapeutics Inc - Company Long-Term Debt|Long-Term Debt PRME (primemedicine.com)|TSHA - Company Long-Term Debt|QURE - Company Long-Term Indebtedness|Company Long-Term Liabilities MeiraGTx PLC (MGTX)|RGNX - Company Long-Term Loans and Borrowings|Solid Biosciences Inc. (SLDB) - Company Long-Term Debts|ocugen.com (OCGN) - Company Long-Term Debt|PACB: Company Long-Term Debts|Long-Term Debt Volume BNTC|Design Pharma - Company Long-Term Debt|Long-Term Debt Rocket Corp RCKT|Company Long-Term Liabilities 4D Molecular Therapeutics|Company Long-Term Loans and Borrowings Lexeo Therapeutics Inc. LXEO|KRRO: Company Long-Term Debts|EDIT: Company Long-Term Liabilities|Company Long-Term Debt SLN|Long-Term Debt ProQR Therapeutics|CDXS: Company Long-Term Liabilities|Long-Term Debt Volume sangamo.com|NAUT: Company Long-Term Debts|Long-Term Indebtedness Metagenomi Inc. (MGX)|Company Long-Term Debts Precision BioSciences DTIL|Company Long-Term Debt Boundless Bio Inc BOLD|Company Long-Term Debts XCUR (Exicure Corp)|IMNN: Long-Term Debt Volume|Company Long-Term Debt PHIO|Mustang Bio (MBIO) - Long-Term Debt|Company Long-Term Debts TransCode Therapeutics Inc. (RNAZ)|Company Long-Term Indebtedness BNGO|Company Long-Term Debt Applied DNA Sciences APDN|Company Long-Term Indebtedness bluebirdbio.com (BLUE)|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Company Long-Term Debts Omega Therapeutics Inc OMGA|Company Long-Term Debts OMIC|RGLS - Long-Term Indebtedness|Company Long-Term Debts SYRS|TBIO (telesisbio.com) - Long-Term Debt|Company Long-Term Debt TRACON Pharmaceuticals, Inc. (TCON)|Company Long-Term Indebtedness Unity Biotechnology Inc.